Augie's Quest moves to ALS TDI!
Invest in iPS @ TDI
Partnership with Neurimmune
Secure funding, develop potential treatments, end ALS
Webinar: How to Get into a Clinical Trial
How to get into a clinical trial with special guests PALS and their caregivers.
ALS TDI Scientists Publish New Findings on TDP43 Mouse
TDI researchers co-authored a paper published about the TDP-43 mouse model.
Webinar: ALS TDI's iPS Program
Discussion about the iPS program with special guest Dr. Matvey Lukashev.
Looking for a clinical trial?
Our database is unbiased, international and updated daily.
Great Boston Chili Bowl
Wake up from winter hibernation! Local restaurants and craft brews come out to f...
February 2014 Update from TDI
Not registered with TDI? Click here to see our latest e-update.
In The Spotlight
A T cell booster shot for PALS?
Low dose IL-2, approaching phase I/II, may help slow ALS by boosting Tregs.
Building resistance to ALS?
Emerging MMP-9 blockers may help slow ALS by shielding MNs from destruction.
Charting the course of ALS
A map of ALS may help scientists design therapies that stop ALS in its tracks.